Description: SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE's portfolio of products and product candidates activate biologic signaling and angiogenic responses, including revascularization and microcirculatory improvement, helping restore the body's normal healing processes and regeneration. SANUWAVE is applying its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.
Home Page: www.sanuwave.com
3360 Martin Farm Road
Suwanee,
GA
30024
United States
Phone:
770 419 7525
Officers
| Name | Title |
|---|---|
| Mr. Kevin A. Richardson II | CEO & Director |
| Mr. Peter Stegagno | Chief Operation Officer |
| Ms. Lisa E. Sundstrom | Chief Talent Officer |
| Dr. Toni Rinow M.B.A., MBA., Ph.D. | Chief Financial Officer |
| Dr. Iulian Cioanta | Chief Science & Technology Officer |
| Mr. Jack Schlechtweg | Chief Revenue Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.0619 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 40 |